Timefolio Capital
Seoul, Seoultimefoliocapital.co.kr
Overview
Timefolio Capital is the corporate venture capital arm of Timefolio Asset Management. Founded in 2015 and based in Seoul, South Korea, the firm invests in companies ranging from venture-stage to small and medium-sized enterprises. Its primary investment focus is on the healthcare and life sciences sectors, particularly therapeutic drugs, as well as technology, software, media, and entertainment.
Portfolio Companies
16
Website
timefoliocapital.co.krInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Avelos Therapeutics | Apr 2024 | Series B | Co-investor |
| Point2 Technology Inc. | Feb 2024 | Series B Extension | Co-investor |
| Accent Therapeutics | Jan 2024 | Series C | Co-investor |
| ChipsK Corp. | Dec 2023 | Series B | Co-investor |
| Inocras | Nov 2023 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?